Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Elena Geuna"'
Autor:
Nicoletta Staropoli, Elena Geuna, Gaetana Rinaldi, Giancarlo Bisagni, Vieri Scotti, Giovanni Faggioni, Laura Vannini, Carlo Arcara, Gabriella Moretti, Marco Gunnellini, Luigi Coltelli, Francesco Verderame, Lorenzo Livi, Giuseppina Sanna, Donatella Grasso, Giulia Abbinante, Francesca Ragni
Publikováno v:
Current Oncology, Vol 29, Iss 9, Pp 6635-6641 (2022)
Ribociclib plus an aromatase inhibitor and ovarian function suppression is the preferred first-line option for pre-/perimenopausal women with hormone receptor-positive/human epidermal growth factor receptor-2-negative advanced or metastatic breast ca
Externí odkaz:
https://doaj.org/article/3f3f4fb521364b87877acb92d608198e
Autor:
Valentina Tuninetti, Luca Pace, Eleonora Ghisoni, Virginia Quarà, Francesca Arezzo, Andrea Palicelli, Vincenzo Dario Mandato, Elena Geuna, Gennaro Cormio, Nicoletta Biglia, Lucia Borsotti, Silvia Gallo, Annamaria Ferrero, Elena Jacomuzzi, Luca Fuso, Jeremy Oscar Smith Pezua Sanjinez, Andrea Puppo, Andrea Caglio, Chiara Rognone, Margherita Turinetto, Giulia Scotto, Massimo Di Maio, Giorgio Valabrega
Publikováno v:
Cancers, Vol 15, Iss 14, p 3639 (2023)
Background: There is poor evidence regarding sensitivity to chemotherapy in endometrial cancer (EC) based on microsatellite instability (MSI)/mismatch repair (MMR) status. Methodology: The RAME study is a retrospective analysis aiming to assess respo
Externí odkaz:
https://doaj.org/article/6ab86d5ec9294299a5042250464490b6
Autor:
Federica Verginelli, Alberto Pisacane, Gennaro Gambardella, Antonio D’Ambrosio, Ermes Candiello, Marco Ferrio, Mara Panero, Laura Casorzo, Silvia Benvenuti, Eliano Cascardi, Rebecca Senetta, Elena Geuna, Andrea Ballabio, Filippo Montemurro, Anna Sapino, Paolo M. Comoglio, Carla Boccaccio
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-16 (2021)
Cancer of unknown primary (CUP) is a mysterious malignancy featuring metastatic dissemination in the absence of a recognizable primary tumor. By characterizing CUP cancer stem cells we show that self-sustained long-term propagation and sensitivity to
Externí odkaz:
https://doaj.org/article/4477922c33134d2989690669cbc5e8c0
Autor:
Ornella Garrone, Massimo Di Maio, Claudia de Angelis, Andrea Michelotti, Matteo Paccagnella, Filippo Montemurro, Anna Maria Vandone, Andrea Abbona, Elena Geuna, Paola Vanella, Cristiana Lo Nigro, Antonella Falletta, Nicola Crosetto, Marco Merlano
Publikováno v:
ESMO Open, Vol 5, Iss 5 (2020)
Background Anticancer drugs can interact with the tumour microenvironment and their effects could be exploited to favour anticancer immune response. Eribulin contributes to tumour vasculature remodelling and transforming growth factor β (TGF-β) mod
Externí odkaz:
https://doaj.org/article/93bef614d1984f27a29a9123b66b2e36
Autor:
Danilo Galizia, Anna Sapino, Filippo Montemurro, Elena Geuna, Annalisa Petrelli, Sara Erika Bellomo, Ivana Sarotto, Franziska Kubatzki, Paola Sgandurra, Furio Maggiorotto, Maria Rosaria Di Virgilio, Riccardo Ponzone, Anna Maria Nuzzo, Enzo Medico, Umberto Miglio, Enrico Berrino, Tiziana Venesio, Salvatore Ribisi, Paolo Provero, Silvia Giordano
Publikováno v:
ESMO Open, Vol 5, Iss 5 (2020)
Purpose Overexpression of miR-100 in stem cells derived from basal-like breast cancers causes loss of stemness, induction of luminal breast cancer markers and response to endocrine therapy. We, therefore, explored miR-100 as a novel biomarker in pati
Externí odkaz:
https://doaj.org/article/f28bb59f51b644c4a57c91d61b43abef
Autor:
Silvia Benvenuti, Melissa Milan, Elena Geuna, Alberto Pisacane, Rebecca Senetta, Gennaro Gambardella, Giulia M Stella, Filippo Montemurro, Anna Sapino, Carla Boccaccio, Paolo M Comoglio
Publikováno v:
EMBO Molecular Medicine, Vol 12, Iss 7, Pp n/a-n/a (2020)
Abstract Cancer of unknown primary (CUP) is an obscure disease characterized by multiple metastases in the absence of a primary tumor. No consensus has been reached whether CUPs are simply generated from cancers that cannot be detected or whether the
Externí odkaz:
https://doaj.org/article/a3a098358273454aa580ffa5d68aa70d
Autor:
Stefan Kolling, Ferdinando Ventre, Elena Geuna, Melissa Milan, Alberto Pisacane, Carla Boccaccio, Anna Sapino, Filippo Montemurro
Publikováno v:
Frontiers in Oncology, Vol 9 (2020)
Cancer of unknown primary (CUP) is an umbrella term used to classify a heterogeneous group of metastatic cancers based on the absence of an identifiable primary tumor. Clinically, CUPs are characterized by a set of distinct features comprising early
Externí odkaz:
https://doaj.org/article/b62d7f192cd64462bad37f49f7d0542c
Autor:
Matteo Paccagnella, Andrea Abbona, Andrea Michelotti, Elena Geuna, Fiorella Ruatta, Elisabetta Landucci, Nerina Denaro, Paola Vanella, Cristiana Lo Nigro, Danilo Galizia, Marco Merlano, Ornella Garrone
Publikováno v:
Vaccines, Vol 10, Iss 1, p 78 (2022)
Cancer induces immune suppression to overcome its recognition and eradication by the immune system. Cytokines are messengers able to modulate immune response or suppression. There is great interest in the evaluation of their changes during treatment
Externí odkaz:
https://doaj.org/article/d9458fc3cfd64e84a35bbb492719cf37
Autor:
Danilo Galizia, Andrea Milani, Elena Geuna, Rossella Martinello, Celeste Cagnazzo, Manuela Foresto, Virginia Longo, Paola Berchialla, Gianfranca Solinas, Adele Calori, Bruna Grasso, Chiara Volpone, Gisella Bertola, Gisella Parola, Giancarla Tealdi, Piero Luigi Giuliano, Anna Maria Ballari, Massimo Aglietta, Filippo Montemurro
Publikováno v:
Cancer Medicine, Vol 7, Iss 9, Pp 4339-4344 (2018)
Abstract Background We recently reported that self‐evaluation of the incidence and severity of treatment‐related side effects (TSEs) using a National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) v4.0‐based quest
Externí odkaz:
https://doaj.org/article/484b3bee40944291884d030fd257ac71
Autor:
Elena Geuna, Pasquale Lombardi, Rossella Martinello, Davide Garino, Alessandro Bonzano, Danilo Galizia, Annamaria Nuzzo, Paola Berchialla, Paolo Becco, Monica Mangioni, Lorena De Zarlo, Filippo Montemurro
Publikováno v:
Cancers, Vol 12, Iss 2, p 327 (2020)
Background: Angiotensin Converting Enzyme inhibitors (ACEis) and beta-blockers (BB) are suggested to prevent and treat trastuzumab-related cardiac toxicity. We performed a prospective clinical trial in women experiencing mild cardiac toxicity (MCT) w
Externí odkaz:
https://doaj.org/article/e56f20424fe948329bcfb493c94dba02